4 Results for "

hNaV1.2

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "hNaV1.2" in MCE Product Catalog:

Cat. No.: HY-157786
CAS No.: 2230145-14-7
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

XPC-5462 is a selective NaV1.6/1.2 inhibitor, with an IC50 of 0.0103 μM against hNaV1.6, 0.0137 μM against mNaV1.6, and 0.0109 μM against hNaV1.2. XPC-5462 significantly reduces epileptiform discharges. XPC-5462 is applicable for epilepsy-related research .
loading...
    loading...
Cat. No.: HY-152166
CAS No.: 1199944-04-1
Purity:  98.89%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

NaV1.2/1.6 channel blocker-1 is a potent NaV1.2/1.6 channel blocker, with IC50s of 9.8 and 24.4 μM for rNaV1.6 and hNaV1.2, respectively. NaV1.2/1.6 channel blocker-1 can be used for the research of generalized epilepsy .
loading...
    loading...
Cat. No.: HY-126291
CAS No.: 2349371-81-7
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

GNE-616 is a highly potent, metabolically stable, orally bioavailable, and subtype selective Nav1.7 inhibitor (Ki of 0.79 nM and Kd of 0.38 nM for hNav1.7) for the treatment of chronic pain. GNE-616 shows >1000 nM Kd and >2500-fold selectivity over hNav1.1, hNav1.3, hNav1.4, and hNav1.5. Selectivity over hNav1.2 and hNav1.6 is more modest at 31- and 73-fold, respectively .
loading...
    loading...
Cat. No.: HY-P5900
Synonyms: m3-HwTx-IV
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

m3-Huwentoxin IV (m3-HwTx-IV) is a potent NaV inhibitor with IC50s of 3.3, 6.8, 7.2, 8.4, 11.9 and 369 nM against hNaV1.7, hNaV1.6, hNaV1.3, hNaV1.1, hNaV1.2 and hNaV1.4, respectively in QPatch assay. m3-Huwentoxin IV dose-dependently suppresses spontaneous pain induced by the NaV1.7 activator OD1 in a rodent pain model .
loading...
    loading...